InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Parlati Francesco, Directeur. Director active across 1 company, notably Calithera Biosciences, Inc.. Cumulatively, 4 filings have been published. Activity tracked since 27 October 2021. The latest transaction was disclosed on 5 November 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Parlati Francesco is SR. VP of research at Calithera Biosciences, Inc., a biopharmaceutical company. He oversees research and development programs, contributing to innovation and advancement in medical treatments.